Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Endpoint summary

Currently viewing:

Administrative data

Description of key information

potentially skin sensitising

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

There is no skin sensitization test for 1-methyl piperazine and due to the corrosive properties to the skin, it not considered ethical to perform a skin sensitization test in animals.
For the endpoint skin sensitization a QSAR calculation for test substance was made using the software OASIS TIMES v.2.30.1.11 The model Skin sensitization was used. The substance falls not in the applicability domain of the model. The test substance is considered to be a strong sensitizer but out of domain.
For the endpoint skin sensitization a QSAR calculation for test substance was made using the software Derek Nexus: 6.1.0, Nexus: 2.3.0 (Lhasa Limited). The substance falls in the applicability domain of the model. The test substance is considered to be skin sensitizing.


Thus, a classification of Category 1B for skin sensitization based on the EU CLP (GHS) criteria is considered justified.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

There is no skin sensitization test for 1-methyl piperazine available and due to the corrosive properties to the skin, it not considered ethical to perform a skin sensitization test in animals. In silico data (QSAR) support a classification of Category 1B for skin sensitization based on the EU CLP (GHS) criteria.


As there are no data for respiratory sensitisation available, it is concluded that 1-methyl piperazine is not to be classified as a respiratory sensitizer.